Cure: FDA approves tablet form of blood cancer treatment
UC expert says more patients may potentially benefit from approval
Following positive results of clinical trials, the Food and Drug Administration recently approved a tablet version of a drug called Calquence for the treatment of chronic lymphocytic leukemia (CLL), small lymphocytic leukemia (SLL) and previously treated relapsed or refractory mantle cell lymphoma (MCL).
The drug was previously approved in capsule form, but the tablet form is able to be given to patients who are also taking drugs that reduce gastric acid.
"Patients with blood cancers like chronic lymphocytic leukemia and mantle cell lymphoma are often older and may face multiple medical conditions that may need intervention, including acid reflux or peptic ulcer disease,” John Byrd, MD, University of Cincinnati Cancer Center member, Gordon and Helen Hughes Taylor Endowed Chair and professor in the Department of Internal Medicine in UC's College of Medicine and a UC Health physician, told the publication Cure. “This provides another option for some patients with chronic lymphocytic leukemia and relapsed or refractory mantle cell lymphoma, enabling more patients to potentially benefit from this treatment.”
Read the Cure article.
Featured photo of John Byrd, MD. Photo/University of Cincinnati.
Related Stories
UC co-op helps build career pathways at AtriCure
July 28, 2026
AtriCure, a global medical device company in Mason, Ohio, is UC’s largest biomedical engineering co-op employer, turning University of Cincinnati co-op students into full-time innovators.
CCM welcomes new musical theatre faculty member Avery Bargassé
July 28, 2026
UC College-Conservatory of Music Dean Pete Jutras has announced the appointment of Avery Bargassé as CCM's new Assistant Professor Educator of Musical Theatre Voice. His faculty appointment officially begins on Aug. 15, 2026. Bargassé is a versatile vocalist, recording artist and voice teacher whose career spans television, popular music and classical singing. He approaches teaching from a whole-person perspective, helping students develop healthy, flexible technique that supports expressive communication across styles.
UC doctoral student shares his journey with Spectrum News
July 27, 2026
UC doctoral student Amota Ataneka spoke with Spectrum News about his educational journey. Ataneka, a native of the Pacific island nation of Kiribati, is one of 35 emerging scholars across the United States to win the National Academy of Education/Spencer Dissertation Fellowship.